A novel approach to managing COVID-19 patients: results of lopinavir plus doxycycline cohort—authors’ reply

Detalles Bibliográficos
Autores principales: Cag, Yasemin, Vahaboglu, Haluk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804901/
https://www.ncbi.nlm.nih.gov/pubmed/33439342
http://dx.doi.org/10.1007/s10096-020-04099-w
_version_ 1783636208513974272
author Cag, Yasemin
Vahaboglu, Haluk
author_facet Cag, Yasemin
Vahaboglu, Haluk
author_sort Cag, Yasemin
collection PubMed
description
format Online
Article
Text
id pubmed-7804901
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-78049012021-01-13 A novel approach to managing COVID-19 patients: results of lopinavir plus doxycycline cohort—authors’ reply Cag, Yasemin Vahaboglu, Haluk Eur J Clin Microbiol Infect Dis Letter to the Editor Springer Berlin Heidelberg 2021-01-13 2021 /pmc/articles/PMC7804901/ /pubmed/33439342 http://dx.doi.org/10.1007/s10096-020-04099-w Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Cag, Yasemin
Vahaboglu, Haluk
A novel approach to managing COVID-19 patients: results of lopinavir plus doxycycline cohort—authors’ reply
title A novel approach to managing COVID-19 patients: results of lopinavir plus doxycycline cohort—authors’ reply
title_full A novel approach to managing COVID-19 patients: results of lopinavir plus doxycycline cohort—authors’ reply
title_fullStr A novel approach to managing COVID-19 patients: results of lopinavir plus doxycycline cohort—authors’ reply
title_full_unstemmed A novel approach to managing COVID-19 patients: results of lopinavir plus doxycycline cohort—authors’ reply
title_short A novel approach to managing COVID-19 patients: results of lopinavir plus doxycycline cohort—authors’ reply
title_sort novel approach to managing covid-19 patients: results of lopinavir plus doxycycline cohort—authors’ reply
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804901/
https://www.ncbi.nlm.nih.gov/pubmed/33439342
http://dx.doi.org/10.1007/s10096-020-04099-w
work_keys_str_mv AT cagyasemin anovelapproachtomanagingcovid19patientsresultsoflopinavirplusdoxycyclinecohortauthorsreply
AT vahabogluhaluk anovelapproachtomanagingcovid19patientsresultsoflopinavirplusdoxycyclinecohortauthorsreply
AT cagyasemin novelapproachtomanagingcovid19patientsresultsoflopinavirplusdoxycyclinecohortauthorsreply
AT vahabogluhaluk novelapproachtomanagingcovid19patientsresultsoflopinavirplusdoxycyclinecohortauthorsreply

Ejemplares similares